Occludin Antikörper (AA 285-430)
Quick Overview for Occludin Antikörper (AA 285-430) (ABIN7162123)
Target
Alle Occludin (OCLN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 285-430
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Occludin protein (285-430AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Occludin (OCLN)
-
Andere Bezeichnung
- OCLN
-
Hintergrund
-
Background: May play a role in the formation and regulation of the tight junction (TJ) paracellular permeability barrier. It is able to induce adhesion when expressed in cells lacking tight junctions.
Aliases: BLCPMG antibody, FLJ08163 antibody, FLJ18079 antibody, FLJ77961 antibody, FLJ94056 antibody, MGC34277 antibody, Occludin antibody, Ocln antibody, OCLN_HUMAN antibody, Phosphatase 1 regulatory subunit 115 antibody, PPP1R115 antibody, PTORCH1 antibody, Tight junction protein occludin antibody
-
UniProt
- Q16625
-
Pathways
- Cell-Cell Junction Organization, Hepatitis C
Target
-